Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37883739

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Jan 1
First author
Luminari S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Luminari S
      type
      Author
    2. name
      Fossa A
      type
      Author
    3. name
      Trotman J
      type
      Author
    4. name
      Molin D
      type
      Author
    5. name
      d'Amore F
      type
      Author
    6. name
      Enblad G
      type
      Author
    7. name
      Berkahn L
      type
      Author
    8. name
      Barrington SF
      type
      Author
    9. name
      Radford J
      type
      Author
    10. name
      Federico M
      type
      Author
    11. name
      Kirkwood AA
      type
      Author
    12. name
      Johnson PWM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Luminari S
      type
      Author
    2. name
      Fossa A
      type
      Author
    3. name
      Trotman J
      type
      Author
    4. name
      Molin D
      type
      Author
    5. name
      d'Amore F
      type
      Author
    6. name
      Enblad G
      type
      Author
    7. name
      Berkahn L
      type
      Author
    8. name
      Barrington SF
      type
      Author
    9. name
      Radford J
      type
      Author
    10. name
      Federico M
      type
      Author
    11. name
      Kirkwood AA
      type
      Author
    12. name
      Johnson PWM
      type
      Author
    bibliography ids
    1. nci-bib-e8370af68b263dfa2ba1ec50
    book metadata
    content sha256
    384de8a431833ac3a5faef737efcf80c29585268b3a2ba02925e0736b16825aa
    document type
    citation
    dois
    1. 10.1200/JCO.23.01177
    electronic publication date
    display
    2023 Oct 26
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37883739
    immutable id
    pubmed:37883739@384de8a431833ac3a5faef737efcf80c29585268b3a2ba02925e0736b16825aa
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    1
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    13-18
    volume
    42
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37883739
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      64ecfe377c8c1a500592ad3670cd739c77ba6fceb47a270e531075c9a6b99ff6
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Jan 1
      precision
      day
      year
      2024
      publication types
      1. Equivalence Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37883739/
      title
      Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.

      Preserved source evidence · Not medical advice